glp 1 drug manufacturers How GLP-1 medications are transforming diabetes and weight loss treatment GLP-1 Drugs from the Gray

2-11 Modest reductions in weight of 5 to 10% can produce clinically significant improvements in CVD risk factors

Circulation 142(17):e265e286 American Diabetes Association Professional Practice Committee (2024) 10

The first is the introduction of oral pills, which, along with being easier to use, also remove the necessity of cold-chain supply the requirement that injectables be kept at a low temperature before they reach users which will help GLP-1s reach areas that otherwise would not be able to support these refrigeration needs

In the study by Kuhadiya et al

GLP-1 lawsuits allege that manufacturers failed to provide adequate warnings as these medications moved from diabetes treatment into widespread weight-loss use

DM: Writing original draft, Investigation, Formal analysis, Data curation